Interleukin-2 Injection for Melanoma Therapy from China

Recombinant human IL-2 in single-dose vials for retail, an immunological cytokine stimulating T-cell response in cancer immunotherapy. HTS 3002.15.00.91 applies as it matches chapter note for interleukins as immunological products in measured retail packs.

Duty Rate — China → United States

0%

Rate breakdown

9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter

Import Tips

Provide stability data for shipping; IL-2 degrades above 8°C, risking total loss

Declare as 'biotech-derived' to support immunological classification

Watch for reclassification if sold in multi-dose bulk for hospitals